Abstract
In order to assess the importance of the intensity of administration of chemotherapy in the management of advanced germ cell tumours we have calculated indices of chemotherapy. These have been used to compare the treatment given to patients who subsequently relapsed with matched controls who did not relapse. Two of these indices (alpha and beta) are derived from the doses of drugs whose dose is varied (cisplatinum, methotrexate and etoposide). These indices showed significant variation between cases and controls. Indices gamma and delta are derived from drugs whose dose is not varied. They showed no significant differences between the two groups. These results emphasise the importance of ensuring that patients with these curable cancers receive adequate doses of chemotherapy.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Biomarkers, Tumor / analysis
-
Bleomycin / administration & dosage
-
Chorionic Gonadotropin / blood
-
Cyclophosphamide / administration & dosage
-
Cytarabine / administration & dosage
-
Dactinomycin / administration & dosage
-
Drug Administration Schedule
-
Etoposide / administration & dosage
-
Female
-
Humans
-
Methotrexate / administration & dosage
-
Neoplasms, Germ Cell and Embryonal / blood
-
Neoplasms, Germ Cell and Embryonal / drug therapy*
-
Vincristine / administration & dosage
-
alpha-Fetoproteins / analysis
Substances
-
Biomarkers, Tumor
-
Chorionic Gonadotropin
-
alpha-Fetoproteins
-
Cytarabine
-
Bleomycin
-
Dactinomycin
-
Vincristine
-
Etoposide
-
Cyclophosphamide
-
Methotrexate